HSD45 Breast Cancer Biopsy Rates in Chile: Is There Justification for Adopting Innovative Anatomic Pathology Technologies in Public Providers?
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1388
https://www.valueinhealthjournal.com/article/S1098-3015(22)03593-8/fulltext
Title :
HSD45 Breast Cancer Biopsy Rates in Chile: Is There Justification for Adopting Innovative Anatomic Pathology Technologies in Public Providers?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03593-8&doi=10.1016/j.jval.2022.09.1388
First page :
Section Title :
Open access? :
No
Section Order :
10940